NetworkNewsBreaks Archive - Page 389 of 1742

WednesdayJun 08, 2022 11:41 am

NetworkNewsBreaks – Home Bistro Inc. (HBIS) Engages Alab Group for Brand Strategy Expertise

Home Bistro (OTC: HBIS), a leading online meal delivery platform that offers celebrity chef-inspired, gourmet and lifestyle ready-made meals, today announced that it has retained public relations firm Alab Group, known for its work across hospitality, food and lifestyle initiatives, to assist in the development of new brand strategies. Under the collaboration, Alab will work with an initial focus on Home Bistro to oversee, develop and execute an overarching communication strategy with a secondary phase to support the Model Meals’ brand. “Our new relationship with Alab is extremely important to the company’s continued growth,” said Home Bistro’s Chief Marketing Officer…

WednesdayJun 08, 2022 11:30 am

NetworkNewsBreaks – Houston Natural Resources Corp. (HNRC) Announces $10M Acquisition of Water Treatment Company

Houston Natural Resources (OTC: HNRC) has entered into an agreement to acquire additional wastewater treatment facilities; the strategic move aligns with the company’s focus on developing a network of wastewater treatment facilities. According to the announcement, the acquisition, which should close this month, involves a water-well services and drilling company. The company has a recurring customer/service revenue of 68% with a projected recurring customer/service revenue of 80% looking forward. The seven-year-old company focuses in municipal, mining, industrial and agricultural water wells and pump systems with operations in the western region of the country; the company’s fleet includes both small and…

TuesdayJun 07, 2022 1:03 pm

NetworkNewsBreaks – Eat Well Investment Group Inc.’s (CSE: EWG) (OTC: EWGFF) Products Gaining Increased Distribution Amid Growing Interest in Plant-Based Foods

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) is “a vertically integrated plant-based foods investment company that has been rapidly building its portfolio of production and distribution brands during the past year to market to growing consumer interest. Bloomberg Intelligence analysis reported expectations that the market will see explosive growth in coming years, forecasting plant-based foods will increase their representation in the global market to 7.7% by 2030 with an exponential increase in valuation to more than $162 billion,” a recent article reads. “Eat Well’s three major investments — ingredients processor Belle Pulses, food creator Sapientia, and baby food brand…

TuesdayJun 07, 2022 12:52 pm

NetworkNewsBreaks – Why Odyssey Health Inc. (ODYY) Is ‘One to Watch’

Odyssey Health (OTC: ODYY) is a medical technology company focused on developing lifesaving products that offer technological and clinical advantages over current standards of care. Guided by a senior management team with significant experience relating to refining acquired technologies, building commercial systems, and forging strategic partnerships, the company boasts a diverse development portfolio spanning both pharmaceutical candidates and medical devices. “Odyssey has two pharmaceutical products in development: PRV-002 and PRV-001. PRV-002 is a novel compound for the treatment of concussion, which currently has no FDA-approved drug. In pre-clinical studies, PRV-002 has been shown to significantly improve both neuroscore and memory…

TuesdayJun 07, 2022 11:26 am

NetworkNewsBreaks – Coinbase Global Inc. (NASDAQ: COIN) Announces Participation in Upcoming Morgan Stanley US Financials, Payments & CRE Conference

Coinbase Global Inc. (NASDAQ: COIN) will be presenting at the next Morgan Stanley US Financials, Payments & CRE Conference. The company announced that Brett Tejpaul, head of Coinbase Institutional, will be part of a fireside chat at the Morgan Stanley conference. The presentation is slated for Monday, June 13, 2022, with the fireside chat scheduled to start at 3:15 p.m. ET. Those interested can watch the live presentation on the Coinbase investor relations website; a replay of the presentation will also be available. Started in 2012, Coinbase was established with the goal of building a more fair, accessible, efficient and…

TuesdayJun 07, 2022 11:16 am

NetworkNewsBreaks – SPYR Technologies (SPYR) Announces FCC Approval, PTCRB Certification of GeoTraq’s Tracker Module

SPYR (OTCQB: SPYR), a technology company, today announced that its subsidiary GeoTraq’s Tracker Module (“GT-TM100”) is FCC approved and ready for the market. According to the update, the GT-TM100 has successfully completed certification testing required by the PCS Type Certification Review Board (“PTCRB”) and is in compliance with FCC Part 15 Subpart B, Class B (“sDoC”) performance specifications. The PTCRB program provides confidence that devices perform optimally on mobile wireless networks and conform with global standards. “The Tracker Module is a complete, ‘self-contained’ device that can easily be inserted into any device, asset or package to connect it to the…

TuesdayJun 07, 2022 11:06 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Acquisition of Entheon Biomedical’s DMT Clinical Study

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has entered an agreement to acquire the largest phase 1 DMT study conducted to date. The acquisition, conducted through Cybin IRL Limited, a wholly owned subsidiary of Cybin, is expected to accelerate Cybin’s CYB004 program timeline by an estimated nine months; CYB004 is Cybin’s proprietary deuterated DMT molecule designed for the potential treatment of anxiety disorders.. The phase 1 N,N-dimethyltryptamine (“DMT”) study is focused on evaluating pharmacokinetics/pharmacodynamics of DMT currently underway and is expected to significantly impact the clinical path forward. Renamed CYB004-E, the phase 1 EBRX-101…

TuesdayJun 07, 2022 10:12 am

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Closes $5M Direct, Private Placement Offerings

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, has closed on its registered direct offering and concurrent private placement with a single healthcare-focused institutional investor; the offerings were priced at-the-market under Nasdaq rules. According to the announcement, for the registered direct offering, INM issued 4,079,256 common shares at a purchase price of $0.858 per share (or prefunded warrant in lieu thereof). For the concurrent private placement, InMed issued and sold to the investor 1,748,250 common shares (or prefunded warrant in lieu thereto); those shares were offered at the same purchase price as…

MondayJun 06, 2022 3:34 pm

NetworkNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Earns “In-Process” Rating from US Government FedRAMP Program

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies committed to enhancing U.S. security operations, announced that as part of its efforts to pursue Authority to Authorize (“ATO”) in the Federal Risk and Authorization Management Program (“FedRAMP”), the company achieved “In-Process” status. A government-wide program that promotes the adoption of secure cloud services across the federal government, FedRAMP provides a standardized approach to security assessment and authorization, and provides continuous monitoring for cloud products and services. Knightscope has been working to design a secure, hardened environment specifically to support government clients; as part of those efforts, the company built…

MondayJun 06, 2022 3:15 pm

NetworkNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) Immune Monitoring Platform ‘Is the Right Technology at the Right Time’

Aditxt (NASDAQ: ADTX) recently entered into a multi-year partnership with Guthy-Renker LLC- affiliated GRS. The partnership focuses on building awareness and visibility among consumers and health care providers for the proprietary AditxtScore(TM) Immune Monitoring Platform. “AditxtScore is the right technology at the right time. Our first application, AditxtScore for COVID-19, delivers timely reports on vulnerability and immune status to SARS-CoV-2 and its known variants, giving consumers and their physicians the data they need to make informed health decisions for themselves and their families,” Aditxt CEO and Co-Founder Amro Albanna was quoted in a recent article. Albanna added that the company’s…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

NetworkNewsBreaks